These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 10907314)
1. Genetic versus environmental interactions in the oesophagitis-metaplasia-dysplasia-adenocarcinoma sequence (MCS) of Barrett's oesophagus. Ransford RA; Jankowski JA Acta Gastroenterol Belg; 2000; 63(1):18-21. PubMed ID: 10907314 [TBL] [Abstract][Full Text] [Related]
2. Barrett's esophagus: metaplastic cells with loss of heterozygosity at the APC gene locus are clonal precursors to invasive adenocarcinoma. Zhuang Z; Vortmeyer AO; Mark EJ; Odze R; Emmert-Buck MR; Merino MJ; Moon H; Liotta LA; Duray PH Cancer Res; 1996 May; 56(9):1961-4. PubMed ID: 8616831 [TBL] [Abstract][Full Text] [Related]
5. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754 [TBL] [Abstract][Full Text] [Related]
6. [Polymorphism/loss of heterozygosity of APC gene in GERD-Barrett's metaplasia-dysplasia-adenocarcinoma sequence]. Mokrowiecka A; Wierzchniewska-Ławska A; Smolarz B; Romanowicz-Makowska H; Malecka-Panas E Pol Merkur Lekarski; 2009 May; 26(155):385-9. PubMed ID: 19606680 [TBL] [Abstract][Full Text] [Related]
7. Review article: management of oesophageal adenocarcinoma -- control of acid, bile and inflammation in intervention strategies for Barrett's oesophagus. Jankowski JA; Anderson M Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 5():71-80; discussion 95-6. PubMed ID: 15456468 [TBL] [Abstract][Full Text] [Related]
8. Management of Barrett's esophagus free of dysplasia. DeMeester SR Semin Thorac Cardiovasc Surg; 1997 Jul; 9(3):279-84. PubMed ID: 9263346 [TBL] [Abstract][Full Text] [Related]
9. Barrett's oesophagus and oesophageal adenocarcinoma: how does acid interfere with cell proliferation and differentiation? Fitzgerald RC Gut; 2005 Mar; 54 Suppl 1(Suppl 1):i21-6. PubMed ID: 15711004 [TBL] [Abstract][Full Text] [Related]
10. Histopathologic evaluation of an animal model for Barrett's esophagus and adenocarcinoma of the distal esophagus. Buskens CJ; Hulscher JB; van Gulik TM; Ten Kate FJ; van Lanschot JJ J Surg Res; 2006 Oct; 135(2):337-44. PubMed ID: 16926029 [TBL] [Abstract][Full Text] [Related]
11. Dietary inflammatory index and risk of reflux oesophagitis, Barrett's oesophagus and oesophageal adenocarcinoma: a population-based case-control study. Shivappa N; Hebert JR; Anderson LA; Shrubsole MJ; Murray LJ; Getty LB; Coleman HG Br J Nutr; 2017 May; 117(9):1323-1331. PubMed ID: 28571591 [TBL] [Abstract][Full Text] [Related]
12. Molecular biology of Barrett's cancer. Atherfold PA; Jankowski JA Best Pract Res Clin Gastroenterol; 2006; 20(5):813-27. PubMed ID: 16997163 [TBL] [Abstract][Full Text] [Related]
13. The metabolic marker tumour pyruvate kinase type M2 (tumour M2-PK) shows increased expression along the metaplasia-dysplasia-adenocarcinoma sequence in Barrett's oesophagus. Koss K; Harrison RF; Gregory J; Darnton SJ; Anderson MR; Jankowski JA J Clin Pathol; 2004 Nov; 57(11):1156-9. PubMed ID: 15509675 [TBL] [Abstract][Full Text] [Related]
14. Barrett's oesophagus: microsatellite analysis provides evidence to support the proposed metaplasia-dysplasia-carcinoma sequence. Gleeson CM; Sloan JM; McGuigan JA; Ritchie AJ; Weber JL; Russell SE Genes Chromosomes Cancer; 1998 Jan; 21(1):49-60. PubMed ID: 9443041 [TBL] [Abstract][Full Text] [Related]
15. Apoptosis and cell proliferation in the metaplasia-dysplasia-carcinoma-sequence of Barrett's esophagus. Halm U; Tannapfel A; Breitung B; Breidert M; Wittekind CW; Mössner J Hepatogastroenterology; 2000; 47(34):962-6. PubMed ID: 11020858 [TBL] [Abstract][Full Text] [Related]
16. LOH at the sites of the DCC, APC, and TP53 tumor suppressor genes occurs in Barrett's metaplasia and dysplasia adjacent to adenocarcinoma of the esophagus. Dolan K; Garde J; Walker SJ; Sutton R; Gosney J; Field JK Hum Pathol; 1999 Dec; 30(12):1508-14. PubMed ID: 10667431 [TBL] [Abstract][Full Text] [Related]
17. Mutation analysis of the p53, APC, and p16 genes in the Barrett's oesophagus, dysplasia, and adenocarcinoma. González MV; Artímez ML; Rodrigo L; López-Larrea C; Menéndez MJ; Alvarez V; Pérez R; Fresno MF; Pérez MJ; Sampedro A; Coto E J Clin Pathol; 1997 Mar; 50(3):212-7. PubMed ID: 9155671 [TBL] [Abstract][Full Text] [Related]
18. Increasing expression of hypoxia-inducible proteins in the Barrett's metaplasia-dysplasia-adenocarcinoma sequence. Griffiths EA; Pritchard SA; McGrath SM; Valentine HR; Price PM; Welch IM; West CM Br J Cancer; 2007 May; 96(9):1377-83. PubMed ID: 17437013 [TBL] [Abstract][Full Text] [Related]
19. Esophageal adenocarcinoma arising in cervical inlet patch with synchronous Barrett's esophagus-related dysplasia. Tanaka M; Ushiku T; Ikemura M; Shibahara J; Seto Y; Fukayama M Pathol Int; 2014 Aug; 64(8):397-401. PubMed ID: 25143128 [TBL] [Abstract][Full Text] [Related]
20. Barrett's esophagus and risk of esophageal adenocarcinoma. Cossentino MJ; Wong RK Semin Gastrointest Dis; 2003 Jul; 14(3):128-35. PubMed ID: 14653412 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]